Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects

• Published in: Frontiers in immunology Vol. 11; p. 585880
• Main Authors: Gough, Portia, Myles, Ian A.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 25.11.2020
• Subjects: epithelial to mesenchymal transition; Immunology; NF-kappa B; signaling/signaling pathways; TNF; TNF blockade; TNF receptor; epithelial to mesenchymal transition; TNF receptor; NF-kappa B; signaling/signaling pathways; TNF; TNF blockade
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2020.585880

Since its discovery in 1975, TNFα has been a subject of intense study as it plays significant roles in both immunity and cancer. Such attention is well deserved as TNFα is unique in its engagement of pleiotropic signaling via its two receptors: TNFR1 and TNFR2. Extensive research has yielded mechanistic insights into how a single cytokine can provoke a disparate range of cellular responses, from proliferation and survival to apoptosis and necrosis. Understanding the intracellular signaling pathways induced by this single cytokine via its two receptors is key to further revelation of its exact functions in the many disease states and immune responses in which it plays a role. In this review, we describe the signaling complexes formed by TNFR1 and TNFR2 that lead to each potential cellular response, namely, canonical and non-canonical NF-κB activation, apoptosis and necrosis. This is followed by a discussion of data from in vivo mouse and human studies to examine the differential impacts of TNFR1 versus TNFR2 signaling.